Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2012; 18(8): 840-846
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.840
Published online Feb 28, 2012. doi: 10.3748/wjg.v18.i8.840
Table 1 The clinical data of 134 pancreatic ductal adenocarcinoma patients
| Items | Category | n (%) |
| Age (yr) | ≤ 60 | 63 (47.0) |
| > 60 | 71 (53.0) | |
| Gender | Male | 92 (68.7) |
| Female | 42 (31.3) | |
| Location of tumor | Head | 97 (72.4) |
| Body/tail | 37 (27.6) | |
| Size of tumor (cm)1 | ≤ 2.0 | 17 (13.2) |
| > 2.0 | 112 (86.8) | |
| Histological grade | G1 | 3 (2.2) |
| G2 | 116 (86.6) | |
| G3 | 15 (11.2) | |
| Perineural invasion | Absent | 25 (18.7) |
| Present | 109 (81.3) | |
| pT1 | T1 | 10 (7.6) |
| T2 | 43 (32.8) | |
| T3 | 46 (35.1) | |
| T4 | 32 (24.4) | |
| pN1 | Absent | 84 (65.1) |
| Present | 45 (34.9) | |
| pTNM1 | I | 32 (24.8) |
| II | 30 (23.3) | |
| III | 33 (25.6) | |
| IV | 34 (26.4) |
- Citation: Shi M, Yu DH, Chen Y, Zhao CY, Zhang J, Liu QH, Ni CR, Zhu MH. Expression of fibroblast activation protein in human pancreatic adenocarcinoma and its clinicopathological significance. World J Gastroenterol 2012; 18(8): 840-846
- URL: https://www.wjgnet.com/1007-9327/full/v18/i8/840.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i8.840